pages: 1 / 3   következő  
Gábor Somlyai’s lecture in Washington 2017. 11. 14.
Gábor Somlyai PhD gave a lecture as an invited speaker at the III. International Conference on Clinical Sciences and Drug Discovery in Washington, on 9 November 2017.
Gábor Somlyai’s visit to China 2017. 09. 18.
Gábor Somlyai PhD gave a lecture as an invited key-note speaker at the 7th International Academic Forum of Negative Hydrogen Ions in Shanghai, on 16 September 2017.
FuturAqua to invest HUF 400 mln in cancer research 2016. 12. 02.
 MTI – Econews
PREVENTA deuterium-depleted drinking water product line received a MagyarBrands award 2016. 11. 23.
HYD Pharma Receives Ethical Approval for Phase 2 Clinical Trial Investigating the Anticancer Effect of Deuterium Depletion in CL 2016. 07. 18.
HYD Pharma Inc. has been granted ethical approval by the State Institute for Drug Control (SIDC) in Slovakia for Phase 2 as one-of-the-first clinical trials to prove the anticancer effect of...
HYD Pharma Receives GMP Certification for Deuterium-Depleted Water (DDW) Production Facility 2015. 09. 10.
Company will soon apply for ethical approval to start Phase 2 clinical trial in chronic lymphocitic leukemia Budapest, Hungary, 2 September 2015 - Following a successful audition by the Hungarian...
Budapest Business Journal’s report on GMP certification of HYD’s facility 2015. 07. 30.
Budapest Business Journal reported, that Hungarian cancer research and drug developer HYD was awarded good manufacturing practice (GMP) certification and, simultaneously, registered...
Interviews with university professors about deuterium depletion research 2015. 06. 24.
University professors gave interviews at the 3rd International Congress on Deuterium Depletion in Budapest.
Lecture at Harbor UCLA Medical Center – Science Friday 2014. 11. 21.
Partial Deuteration of Hydrogen Bonded Systems and Their Role in Cancer Development
BIO Europe 2014, 20th International Partnering Conference -Frankfurt, November 3-5, 2014. 2014. 11. 11.
Dr. Gabor Somlyai represented HYD Ltd. for Cancer Research and Drug Development at BIO Europe Partnering Conference in Frankfurt between November 3 and 5, 2014.
pages: 1 / 3   következő